Evaluate the Safety and Effectiveness of Electronic Vision-aid Device
NCT ID: NCT05968365
Last Updated: 2023-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2021-02-01
2021-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Wayfinding Information Access System for People With Vision Loss
NCT00829036
Collision Warning Device for Blind and Visually Impaired
NCT03057496
V-NAV Usability Study: End Users Trying the Vortant Indoor Navigation Tool
NCT05647694
Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI)
NCT05186948
Feasibility and Efficacy of Assisstive Tactile and Auditory Communicating Devices
NCT03174314
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
Three centers participated
A total of 36 patients were enrolled. It was developed and produced by Weikan Technology in subjects who agreed to be enrolled
The "Vision Pro" is trained, and after no less than 3 hours of training, the subject is good at it
Evaluate the safety and effectiveness of obstacle perception and recognition in the process of walking, and evaluate the test product in auxiliary sight
Safety and effectiveness of obstacle perception and recognition for disabled walkers.
SUPPORTIVE_CARE
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
electronic Vision-aid Device
Electronic blind aid is a non-invasive electronic aid product for the visually impaired. The product converts visual signals into tactile signals. The Vision Pro is designed for people with poor or no visual perception. The product does not change the previous travel mode of the visually impaired, and provides additional external information for the visually impaired on the basis of their existing cognition. The product can provide the visually impaired person with additional external information based on the cognition in front of them. The product can feedback the environmental information within 2.52.5 meters in front of the visually impaired person in the form of electrical stimulation to the visually impaired person. The visually impaired person can be stimulated by the tongue current to help them identify obstacles and give early warning. Avoid obstacles and give early warning.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Visually impaired people;
3. Primary blind and visually impaired people
4. visual acuity is no light \~ \< 0.02;
5. visual field radius less than 5°);
Exclusion Criteria
2. epileptic seizures;
3. pregnant women; 4.、implanted with electronic medical devices ;
5、 intellectual disability ; 6、 mental illness; 7、 Oral diseases; 8、oral ulcers, herpes, herpes simplex, oral thrush and map tongue; 9、 speech dysfunction, 10、limited mobility and hearing impairment;
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wicab Technologies (Beijing) Co., Ltd.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tongren Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WKKJ-2020001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.